Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials
Statistics in Medicine · 2024
DOI: 10.1002/sim.10158 ↗At a glance
Journal article in Statistics in Medicine, 2024. Written by Wei Wei and 3 co-authors. Institution: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut. Major MEDLINE topics: Propensity Score, Randomized Controlled Trials as Topic, Models, Statistical, Computer Simulation. Cited 8 times so far (Crossref); 37 references. Funded by: NCI NIH HHS, NIDCR NIH HHS, National Cancer Institute.
Abstract (original language)
Among clinical trialists, there has been a growing interest in using external data to improve decision‐making and accelerate drug development in randomized clinical trials (RCTs). Here we propose a novel approach that combines the propensity score weighting (PW) and the multi‐source exchangeability modelling (MEM) approaches to augment the control arm of a RCT in the rare disease setting. First, propensity score weighting is used to construct weighted external controls that have similar observed pre‐treatment characteristics as the current trial population. Next, the MEM approach evaluates the similarity in outcome distributions between the weighted external controls and the concurrent control arm. The amount of external data we borrow is determined by the similarities in pretreatment characteristics and outcome distributions. The proposed approach can be applied to binary, continuous and count data. We evaluate the performance of the proposed PW‐MEM method and several competing approaches based on simulation and re‐sampling studies. Our results show that the PW‐MEM approach improves the precision of treatment effect estimates while reducing the biases associated with borrowing data from external sources.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut.
- Global Biometrics & Data Management, Pfizer Inc, New York, New York, USA.
ORCID profiles: Wei Wei, Satrajit Roychoudhury
Funding
- NCI NIH HHS
- NIDCR NIH HHS
- National Cancer Institute
- National Institute of Dental and Craniofacial Research
Cite
APA
Wei, W., Zhang, Y., Roychoudhury, S., & Alzheimer's Disease Neuroimaging Initiative (2024). Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials. Statistics in Medicine. https://doi.org/10.1002/sim.10158
Vancouver
Wei W, Zhang Y, Roychoudhury S, Alzheimer's Disease Neuroimaging Initiative. Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials. Statistics in Medicine. 2024. doi:10.1002/sim.10158
BibTeX
@article{Wei2024,
author = {Wei, Wei and Zhang, Yunxuan and Roychoudhury, Satrajit and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10158}
}
EUVIMED